http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170048596-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7983f7a24e475bc509ed1333c99efc1b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-529
filingDate 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a3133e1133fa555d0985789b5c2f07c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4ced154f20d50b3b8e3d4645136e07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b13ad16a66b7af97ac789b3dc8a3e52
publicationDate 2017-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20170048596-A
titleOfInvention Macrocyclic RIP2 kinase inhibitors
abstract The present invention relates to compositions containing such compounds which act as macrocyclic compounds and kinase inhibitors, in particular RIP2 and / or mutants thereof, for use in the diagnosis, prevention and / or treatment of RIP2-kinase related diseases . The present invention provides methods for use, for example, as pharmaceuticals or diagnostic reagents.
priorityDate 2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008058126-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013001310-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011146336-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013045653-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467579502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164176114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466051186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407914085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163725186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137013980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163438479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464982074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466710108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465391264

Total number of triples: 30.